sk&f-38393 and morphinans

sk&f-38393 has been researched along with morphinans in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kameyama, T; Toyoshi, T; Ukai, M1
Chen, CF; Chou, YC; Liao, JF; Wang, HH1

Other Studies

2 other study(ies) available for sk&f-38393 and morphinans

ArticleYear
Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    European journal of pharmacology, 1992, Mar-17, Volume: 213, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Grooming; Indoles; Injections, Intraventricular; Male; Mice; Morphinans; Motor Activity; Naltrexone; Sulpiride

1992
Dimemorfan enhances acetylcholine release from rat hippocampal slices.
    Brain research, 2004, May-15, Volume: 1008, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Antipsychotic Agents; Atropine; Carbachol; Cholinergic Agonists; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Hippocampus; In Vitro Techniques; Male; Morphinans; Muscarinic Antagonists; Phenazocine; Potassium Chloride; Rats; Tritium

2004